MHRA Backs Bacteriophage Innovation To Fight Antimicrobial Resistance

 
• By Eliza Slawther

The UK regulator wants to help companies to develop bacteriophages for the treatment of infections. Its first guidance on this topic offers advice to researchers and sets out the regulatory requirements they will need to meet.

Bacteriophages are virus-based therapies that could help to combat antimicrobial resistant infections (Shutterstock)

More from Approval Standards

More from Clinical Trials